Page 6 - 《中国药房》2025年4期
P. 6

Analysis of gemcitabine adverse drug reactions and risk factors in Inner Mongolia ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
            ⋅⋅⋅⋅ YANG Shengnan,SHI Wei,ZHAO Yufang,LIU Zhien,LEI Wenpu,ZHANG Yanan,ZHAO Ke,GUO Hao (486)
          Pharmaceutical care of anti-infective treatment for a case of pulmonary infection due to Alternaria alternata after
            renal transplantation ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ ZHANG Ruixia,WANG Yanping,GAO Shan (491)

          Research advances in the effects of orexin and its receptor-related drugs on depression ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
            ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ JIANG Zhaoshu,CHENG Ming,YANG Jie,CAO Feng,ZHANG Zhen (496)

          Improve effects of aromatase inhibitors on the height of children with short stature  ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
            ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ XIA Mengmeng,XIANG Jinbo,LUO Jun,ZHU Xiaoxia (501)
          Research progress on the anti-tumor effects of traditional Chinese medicine through intervention in the Nrf2/GPX4
            signaling pathway ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ HUANG Jie,LIN Si,JIANG Chunjuan,WEI Ling (507)


































              CHINA    PHARMACY    (Semimonthly)
                           Founded  in  January  1990             Postal  Address
                    Vol.36,  No.4,  Feb.  2025                    129  Daping  Main  Street,Yuzhong  District,Chongqing
          Total  No.790  Published  on   Feb.  28,2025            400042,China
                                                                  Phone
          Responsible  Institution                                +86-23-63830521;+86-23-63830907;+86-23-68586727;
          National  Health  Commission,P.R. China                 +86-23-68586827
          Sponsored  by                                           E-mail
          Chinese  Hospital  Association                          info@china-pharmacy.com
          Chongqing  University  Cancer  Hospital                 Website
          Undertaken  by                                          http://www.china-pharmacy.com
          Journal  Center  of  Chongqing  University  Cancer  Hospital  Online  Submission
          Published  by                                           http://user.china-pharmacy.com
          China  Pharmacy  Editorial  Department                  Printed  by
          Director  of  Editorial  Commission                     Chongqing  Changhong  Printing  Co.,  Ltd.
          TIAN  Jiazheng                                          Distributed  by
          Executive  Deputy  Director  of  Editorial  Commission   China:  Chongqing  Branch  of  China  Post  Group  Co., Ltd.
          WU  Yongzhong                                          (Code  No.78-33)
          Deputy  Director  of  Editorial  Commission             Overseas:  China  International  Book  Trading  Corporation
          WANG  Ying                                             (Code  No.4703SM)
          Chief  of  Journal  Center                              Subscription  Rates
          ZOU  Xiaoyong                                           CNY 15 per issue;CNY 360 per annum
          Editor-in-Chief                                         CSSN   ISSN  1001-0408
          HU  Xin                                                       CN  50-1055/R
          Deputy  Editor-in-Chief                                 CODEN
          LENG  Huaiming;ZOU  Xiaoyong                            ZYHAA4
          Chief  Editor                                           Perennial  Legal  Counsel
          ZHANG  Jian                                             Chongqing  Huali  Wantao  Law  Firm
   1   2   3   4   5   6   7   8   9   10   11